Wěi Li
Author
Alternate names We. Li, Wan‐Jung Li, Wěi Li, W. Li, Wei Li
Institution First Bethune Hospital of Jilin University
Past institutions Chinese Academy of Sciences, Zhongshan Hospital, Fudan University, Yangzhou University, Shanghai Institute of Materia Medica +5 more
ORCID: Yes
H-index: 101
I10-index: 936
Works count: 2,248
Citations count: 62,990
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
2017 · Mark E. Robson, Seock‐Ah Im, et al. · New England Journal of Medicine
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
2014 · Yi‐Long Wu, Caicun Zhou, et al. · The Lancet Oncology
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
2022 · Shanu Modi, William Jacot, et al. · New England Journal of Medicine